Document is current

Any future updates will be listed below

CT-08 Safety and tolerability of omalizumab, a humanized anti-IgE monoclonal antibody in systemic lupus erythematosus (<i>STOP LUPUS</i>)

Crossref DOI link: https://doi.org/10.1136/lupus-2018-lsm.80

Published Online: 2018-09-04

Published Print: 2018-08

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark